Filament Labs is building PatientIO, a patient engagement platform. We give health professionals tools to track & manage their patients when patients are away from the clinic. We specialize in adherence problems for chronic disease therapies, with an initial focus on the infusion & dialysis space, a 14,000 clinic / $27B market.
By early Q1, we will power patient engagement for 20 infusion clinics nationwide. The CEO of our first customer is also an investor in Filament. We also have a relationship with a specialty pharmaceutical supplier, which offers a channel to thousands of clinic locations.
Filament Labs is a Techstars Austin '13 company. Filament's founders have previous exits to WebMD, Expedia & Rev Worldwide.